Breems DA, Boogaerts MA, Dekker AW, Van Putten WL, Sonneveld P, Huijgens PC, Van der Lelie J, Vellenga E, Gratwohl A, Verhoef GE, Verdonck LF, Lowenberg B:
Autologous bone marrow transplantation as consolidation therapy in the treatment of adult patients under 60 years with acute myeloid leukaemia in first complete remission: a prospective randomized Dutch-Belgian Haemato-Oncology Co-operative Group (HOVON) and Swiss Group for Clinical Cancer Research (SAKK) trial
Br J Haematol
2005 Jan;128(1):59-65
Subjects: AML · SCT
Crawley C, Szydlo R, Lalancette M, Bacigalupo A, Lange A, Brune M, Juliusson G, Shimoni A, Gratwohl A, Komarnicki M, Vitek A, Mayer J, Zander A, Sierra J, Rambaldi A, Ringden O, Niederwieser D, Apperley JF:
Outcomes of reduced intensity transplantation for chronic myeloid leukaemia: An analysis of prognostic factors from the Chronic Leukemia Working Party of the EBMT
Blood
106/9:2969-2976 (2005)
Subjects: SCT
De Souza CA, Vigorito AC, Ruiz MA, Nucci M, Dulley FL, Funcke V, Tabak D, Azevedo AM, Byington R, Macedo MC, Saboya R, Penteado Aranha FJ, Oliveira GB, Zulli R, Martins Miranda EC, Azevedo WM, Lodi FM, Voltarelli JC, Simoes BP, Colturato V, De Souza MP, Silla L, Bittencourt H, Piron-Ruiz L, Maiolino A, Gratwohl A, Pasquini R:
Validation of the EBMT risk score in chronic myeloid leukemia in Brazil and allogeneic transplant outcome
Haematologica
2005 Feb;90(2):232-7
Subjects: SCT
Dreger P, Brand R, Milligan D, Corradini P, Finke J, Deliliers GL, Martino R, Russell N, van Biezen A, Michallet M, Niederwieser D:
Reduced-intensity conditioning lowers treatment-related mortality of allogeneic stem cell transplantation for chronic lymphocytic leukemia: A population-matched analysis
Leukemia
19:1029-1033 (2005)
Subjects: CLL · SCT
Gahrton G, Iacobelli S, Apperley J, Bandini G, Björkstrand B, Bladé J, Boiron JM, Cavo M, Cornelissen J, Corradini P, Kröger N, Ljungman P, Michallet M, Russell NH, Samson D, Schattenberg A, Sirohi B, Verdonck LF, Volin L, Zander A, Niederwieser D:
The impact of donor gender on outcome of allogeneic hematopoietic stem cell transplantation for multiple myeloma: reduced relapse risk in female to male transplants
Bone Marrow Transpl
35:609-617 (2005)
Subjects: SCT
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A;:
Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases.
Bone Marrow Transplant
2005 May;35(9):869-79
Subjects: SCT
Gratwohl A:
Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation
Haematologica
2005 Feb;90(2):151
Subjects: SCT
Gratwohl A:
Risk assessment for patients with chronic myeloid leukemia before allogeneic blood or marrow transplantation
Haematologica
2005 Feb;90(2):151
Subjects: SCT
Gratwohl A, Baldomero H, Schmid O, Horisberger B, Bargetzi M, Urbano-Ispizua A:
Change in stem cell source for hematopoietic stem cell transplantation (HSCT) in Europe: a report of the EBMT activity survey 2003.
Bone Marrow Transplant
2005 Oct;36(7):575-90
Subjects: SCT
Gratwohl A, Passweg J, Bocelli-Tyndall C, Fassas A, van Laar JM, Farge D, Andolina M, Arnold R, Carreras E, Finke J, Kotter I, Kozak T, Lisukov I, Lowenberg B, Marmont A, Moore J, Saccardi R, Snowden JA, van den Hoogen F, Wulffraat NM, Zhao XW, Tyndall A:
Autoimmune Diseases Working Party of the European Group for Blood and Marrow Transplantation (EBMT). Autologous hematopoietic stem cell transplantation for autoimmune diseases
Bone Marrow Transplant
2005 May;35(9):869-79
Subjects: SCT
Gratwohl A, Brand R, Frassoni F, Rocha V, Niederwieser D, Reusser P, Einsele H, Cordonnier C:
Acute and Chronic Leukemia Working Parties; Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation. Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time
Bone Marrow Transplant
2005 Nov;36(9):757-69
Subjects: SCT
Griffith LM, Pavletic SZ, Tyndall A, Bredeson CN, Bowen JD, Childs RW, Gratwohl A, van Laar JM, Mayes MD, Martin R, McSweeney PA, Muraro PA, Openshaw H, Saccardi R, Sandmaier BM, Forman SJ, Nash RA:
Workshop participants. Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.
Biol Blood Marrow Transplant
2005 Nov;11(11):862-70
Subjects: SCT
Hegenbart U, Niederwieser D, Sandmaier BM, Maris MB, Shizuru JA, Greinix H, Cordonnier C, Rio B, Gratwohl A, Lange T, Al-Ali H, Storer B, Maloney D, McSweeney P, Chauncey T, Agura E, Bruno B, Maziarz RT, Petersen F, Storb R.:
Treatment for acute myelogenous leukemia by low-dose, total-body, irradiation-based conditioning and hematopoietic cell transplantation from related and unrelated donors
J Clin Oncol
2006 Jan 20;24(3):444-53
Subjects: SCT
Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Maniatis A, Niederwieser D, Ruutu:
Development of leukemia in donor cells after allogeneic stem cell transplantation – a survey of the European Group for Blood and Marrow Transplantation (EBMT)
Haematologica
2005, 90/7:969-975
Subjects: SCT
Kerbauy FR, Storb R, Hegenbart U, Gooley T, Shizuru J, Al-Ali HK, Radich JP, Maloney DG, Agura E, Bruno B, Epner EM, Chauncey TR, Blume KG, Niederwieser D, Sandmaier BM:
Hematopoietic cell transplantation from HLA-identical sibling donors after low-dose radiation-based conditioning for treatment of CML.
Leukemia
2005, 19:990-997
Subjects: SCT
Lange T, Bumm T, Mueller M, Otto S, Al-Ali HK, Grommisch L, Musiol S, Franke C, Krahl R, Niederwieser D, Deininger:
Durability of molecular remission in chronic myeloid leukemia patients treated with imatinib vs allogeneic stem cell transplantation
Leukemia
19/7:1262-1265
Subjects: SCT
Martinez MT, Bucher Ch, Stussi G, Heim D, Buser A, Tsakiris DA, Tichelli A, Gratwohl A, Passweg JR:
Transplant-associated microangiopathy (TAM) in recipients of allogeneic hematopoietic stem cell transplants
Bone Marrow Transplant
2005 Dec;36(11):993-1000
Subjects: SCT
Niederwieser D:
Haematopoietic cell transplantation after reduced intencity contitioning. European Journal of Hospital Pharmacy
European Journal of Hospital Pharmacy
11/5:16-18
Subjects: SCT
Niederwieser D, Cross M, Lange T, Gentilini C, Haffner C, Pönisch W, Raida M, Al-Ali H:
Hematopoietic cell transplantation in acute myeloid leukemia
Hematology
1:118-122
Subjects: SCT
Niederwieser D, Gentilini C, Hegenbart U, Lange T, Becker C, Wang SY, Bartsch K, Pönisch W, Raida M, Al-Ali H:
Allogeneic stem cell transplantation (HCT) following reduced-intensity conditioning in patients with acute
Crit Rev Oncol Hematol
2005 Nov;56(2):275-81
Subjects: SCT
Ruutu T, Corradini P, Gratwohl A, Holler E, Apperley J, Dini G, Schmitz N, Socié G, Niederwieser D:
Use of intrathecal phrophylaxis in allogeneic haematopoietic stem cell transplantation for malignant blood diseases: a survey of the european group for blood and marrow transplantation (EBMT)
Bone Marrow Transpl
35/2:221-224
Subjects: SCT
Schmitz N, Beksac M, Bacigalupo A, Ruutu T, Nagler A, Gluckman E, Russell N, Apperley J, Szerm J, Bradstock K, Buzyn A, Schlegelberger B, Matcham J, Gratwohl A:
Filgrastim-mobilized peripheral blood progenitor cells versus bone marrow transplantation for treating leukemia: 3-year results from the EBMT randomized trial
Haematologica
2005 May;90(5):643-8
Subjects: SCT
Wills S, Lange T, Demehri S, Otto S, Crossmann L, Niederwieser D, Stoffregen E, McWeeney S, Kovacs I, Park B, Druker BJ, Deininger MW:
High-sensitivity detection of BCR-ABL kinase domain mutations in imatinib-naive patients: correlation with clonal cytogenetic evolution but not response to therapy
Blood
106/6:2128-2137
Subjects: SCT
Windrum P, Morris TC, Drake MB, Niederwieser D, Ruutu T:
Variation in dimethyl sulfoxide use in stem cell transplantation: a survey of EBMT centres
Bone Marrow Transplant
36/7:601-603
Subjects: SCT
About us
The objective of the European LeukemiaNet is to integrate the leading leukemia trial groups (CML, AML, ALL, CLL, MDS, CMPD), their interdisciplinary partners (diagnostics, treatment research, registry, guidelines), industry and SMEs across Europe to form a cooperative network for advancements in leukemia-related research and health care and cure.